Lyme disease vaccine
A Lyme disease vaccine is no longer available. The vaccine manufacturer discontinued production in 2002, citing insufficient consumer demand. Protection provided by this vaccine diminishes over time. Therefore, if you received the Lyme disease vaccine before 2002, you are probably no longer protected against Lyme disease.
- Comstedt P, Hanner M, Schüler W, Meinke A, Lundberg U. Design and development of a novel vaccine for protection against Lyme borreliosisexternal icon. PLOS ONE. 2014 Nov 19;9(11):e113294.
- Livey I, O’Rourke M, Traweger A, Savidis-Dacho H, Crowe BA, Barrett PN, Yang X, Dunn JJ, Luft BJ. A new approach to a Lyme disease vaccineexternal icon. Clin Infect Dis 2011 Feb;52 Suppl 3:s266-70.
- Shen AK, Mead PS, Beard CB. The Lyme disease vaccine–a public health perspectiveexternal icon. Clin Infect Dis 2011 Feb;52 Suppl 3:s247-52.
- Wressnigg N, et al. Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trialexternal icon. Lancet Infect Dis 2013 Aug;13(8):680-9.
The HHS Working Group on Lyme and Other Tickborne Diseases presents: Vaccines for Lyme Disease – Past, present, and future
- Welcome and Introduction – Dr. Ben Beard
- Why we need a vaccine for Lyme disease – Dr. Stanley Plotkin
- Potential vaccine strategies and targets for Lyme disease – Dr. Rich Marconi
- A critical appraisal of LYMErix and lessons learned – Dr. Robert Aronowitz
- Progress toward a second generation Lyme vaccine – Dr. Nina Wressnigg
- Summary and conclusions – Dr. Larry Madoff